Catalysts for $COLL
121 tracked
Nov 5, 2026
earnings
COLLEGIUM PHARMACEUTICAL, INC earnings
COLLEGIUM PHARMACEUTICAL, INC
โ
Aug 6, 2026
earnings
COLLEGIUM PHARMACEUTICAL, INC earnings
COLLEGIUM PHARMACEUTICAL, INC
โ
May 7, 2026
earnings
COLLEGIUM PHARMACEUTICAL, INC earnings
COLLEGIUM PHARMACEUTICAL, INC
โ
Mar 10, 2026
approval
QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Mar 9, 2026
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Jan 27, 2026
approval
TAPENTADOL HYDROCHLORIDE โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Dec 22, 2025
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) โ FDA approval
tapentadol hydrochloride ER
โ
Dec 22, 2025
approval
XTAMPZA ER (OXYCODONE) โ FDA approval
oxycodone ER
โ
Dec 22, 2025
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) โ FDA approval
tapentadol hydrochloride ER
โ
Dec 22, 2025
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) โ FDA approval
tapentadol hydrochloride ER
โ
Sep 23, 2025
approval
APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Sep 23, 2025
approval
METHYLPHENIDATE HYDROCHLORIDE โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Sep 23, 2025
approval
RELEXXII (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Sep 23, 2025
approval
JORNAY PM (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Sep 23, 2025
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Sep 23, 2025
approval
QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
COLLEGIUM PHARMACEUTICAL, INC
โ
Oct 31, 2024
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) โ FDA approval
tapentadol hydrochloride ER
โ
Oct 31, 2024
approval
XTAMPZA ER (OXYCODONE) โ FDA approval
oxycodone ER
โ
Oct 31, 2024
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) โ FDA approval
tapentadol hydrochloride ER
โ
Oct 31, 2024
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) โ FDA approval
tapentadol hydrochloride ER
โ
Jun 14, 2024
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) โ FDA approval
tapentadol hydrochloride ER
โ
Jun 14, 2024
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) โ FDA approval
tapentadol hydrochloride ER
โ